Cidara Therapeutics
CDTX
CDTX was delisted on the 6th of January, 2026.
62 hedge funds and large institutions have $56.6M invested in Cidara Therapeutics in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 8 closing their positions.
17% more capital invested
Capital invested by funds: $48.5M → $56.6M (+$8.1M)
16% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 19
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.55% less ownership
Funds ownership: 2.76% → 2.22% (-0.55%)
2% less funds holding
Funds holding: 63 → 62 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$937K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$595K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$332K |
| 4 |
Two Sigma Investments
New York
|
+$312K |
| 5 |
State Street
Boston,
Massachusetts
|
+$290K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$5.64M |
| 2 |
Renaissance Technologies
New York
|
-$1.85M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$1.04M |
| 4 |
Millennium Management
New York
|
-$335K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$296K |
CDTX Hedge Fund Activity: Q1 2021 in Review
62 of the 5,710 institutional investors tracked by Wall St. Rank reported a position in Cidara Therapeutics (CDTX) for Q1 2021, worth a combined $56.6M — up 17% from $48.5M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of CDTX and 7 opened new positions — a net loss of 1 holder — while 19 trimmed existing stakes and 22 added.
The largest buyer was Jacobs Levy Equity Management, adding an estimated $937K. The largest seller was Bellevue Group, exiting entirely with an estimated $5.64M sold.
- 62 institutional investors held Cidara Therapeutics (CDTX) as of Q1 2021, down from 63 in Q4 2020.
- Funds reported $56.6M of Cidara Therapeutics stock for Q1 2021, up 17% quarter-over-quarter.
- 7 funds opened new Cidara Therapeutics positions in Q1 2021 and 8 closed out, a net change of -1 holder.
- The largest Cidara Therapeutics buyer in Q1 2021 was Jacobs Levy Equity Management, an estimated $937K added.
- The largest Cidara Therapeutics seller in Q1 2021 was Bellevue Group, an estimated $5.64M sold.
Based on aggregated 13F filings for Q1 2021.